MedTrace Logo

A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion

NCT00320853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2006-05-03

No results posted yet for this study

Summary

The purpose of the study is to evaluate the change in insulin sensitivity and secretion indices (early markers for development of diabetes) after 4 weeks of a megadose of Vitamin D. This will also help to calculate sample size for and choose an appropriate index for a larger randomized control trial which may be required subsequently.

Conditions

  • Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG

Vitamin D

Sponsors & Collaborators

  • Sitaram Bhartia Institute of Science and Research

    lead OTHER

Principal Investigators

  • Jitendra N Pande, MD · Sitaram Bhartia Institute of Science and Research

  • Jitender Nagpal, MD · Sitaram Bhartia Institute of Science and Research

  • Abhishek Bhartia, ME · Sitaram Bhartia Institute of Science and Research

  • Anupama Singh, MD · Sitaram Bhartia Institute of Science and Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Completion
2006-05-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00320853 on ClinicalTrials.gov